Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lionco Pharmaceutical Group CoSHSE:603669 -0.19%61 Days Inventory is 119.52 as of Mar. 2026, which is 19% below its 10-year median of 147.95. GuruFocus rates SHSE:603669 with a GF Score™ of 61/100 and a GF Value™ of ¥6.83 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 923 Drug Manufacturers companies, Lionco Pharmaceutical Group Co ranks better than 78.44% on this metric.
The historical rank and industry rank for Lionco Pharmaceutical Group Co's Days Inventory or its related term are showing as below:
SHSE:603669'
s Days Inventory Range Over the Past 10 Years
Min: 76.58 Med: 147.95 Max: 197.57
Current: 102.45
During the past 13 years, Lionco Pharmaceutical Group Co's highest Days Inventory was 197.57. The lowest was 76.58. And the median was 147.95.
SHSE:603669's Days Inventory is ranked better than 78.44% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.87
vs SHSE:603669: 102.45
Inventory Turnover measures how fast the company turns over its inventory within a year.
Lionco Pharmaceutical Group Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.76.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Lionco Pharmaceutical Group Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.93.
Lionco Pharmaceutical Group Co (SHSE:603669) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Lionco Pharmaceutical Group Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Lionco Pharmaceutical Group Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Lionco Pharmaceutical Group Co Days Inventory Related Terms
Lionco Pharmaceutical Group Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lionco Pharmaceutical Group Co Days Inventory Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Lionco Pharmaceutical Group Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lionco Pharmaceutical Group Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Lionco Pharmaceutical Group Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Lionco Pharmaceutical Group Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lionco Pharmaceutical Group Co (SHSE:603669) has a Days Inventory of 119.52 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Lionco Pharmaceutical Group Co and its competitors. This is 19% below median its historical median of 147.95. Over the past decade, Lionco Pharmaceutical Group Co's Days Inventory has ranged from 76.58 to 197.57. According to the industry distribution chart, Lionco Pharmaceutical Group Co ranks #199 out of 923 companies in the Drug Manufacturers industry, placing it in the top 21.6%.
Is Lionco Pharmaceutical Group Co's Days Inventory too high?
Lionco Pharmaceutical Group Co's current Days Inventory of 119.52 is 19% below median its 10-year median of 147.95. Over the past 10 years, this metric has ranged from a low of 76.58 to a high of 197.57. The Drug Manufacturers industry median Days Inventory is 164.87. Lionco Pharmaceutical Group Co's value of 119.52 is 27.5% below this industry median. Based on the distribution chart, Lionco Pharmaceutical Group Co ranks #199 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Lionco Pharmaceutical Group Co has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lionco Pharmaceutical Group Co's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Lionco Pharmaceutical Group Co ranks #199 out of 923 companies for Days Inventory. This places Lionco Pharmaceutical Group Co in the top 22% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.87. Lionco Pharmaceutical Group Co's value of 119.52 is 27.5% below this benchmark. Historically, Lionco Pharmaceutical Group Co's own Days Inventory has ranged from 76.58 to 197.57 over the past decade. While the company's 10-year median is 147.95 vs. the industry median of 164.87, Lionco Pharmaceutical Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.87, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lionco Pharmaceutical Group Co's current Days Inventory of 119.52 is 27.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Lionco Pharmaceutical Group Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lionco Pharmaceutical Group Co's current Days Inventory is 119.52, which is 19% below median its own 10-year median of 147.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lionco Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Lionco Pharmaceutical Group Co (SHSE:603669) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥6.83, compared to a current price of ¥5.38 — trading 21.2% below its estimated fair value. The current Days Inventory is 119.52, which is 19% below median its 10-year median of 147.95 and 27.5% below the Drug Manufacturers industry median of 164.87. Lionco Pharmaceutical Group Co's overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Lionco Pharmaceutical Group Co (SHSE:603669), the current Days Inventory is 119.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lionco Pharmaceutical Group Co (SHSE:603669) Overvalued in 2026?
Based on GuruFocus' analysis, Lionco Pharmaceutical Group Co stock appears to be undervalued.
The current stock price of ¥5.38 is trading 21.2% below its estimated GF Value™ of ¥6.83.
GuruFocus considers Lionco Pharmaceutical Group Co to be Modestly Undervalued.
Key valuation signals for SHSE:603669:
Days Inventory: 119.52 (19% below median its 10-year median of 147.95)
GF Value™: ¥6.83 vs. price of ¥5.38 (21.2% below fair value)
Industry Position: 27.5% below the Drug Manufacturers median (#199 of 923)
No single metric tells the full story. See the SHSE:603669 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lionco Pharmaceutical Group Co Ltd is engaged in the research and development of medicines. The product portfolio includes - Alanyl glutamine for injection, fructose for injection, inverted sugar for injection, xylitol for injection, riboflavin sodium phosphate for injection, and water-soluble vitamin for injection.
61GF Score
Get the complete analysis for SHSE:603669
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603669 has been successfully added to your 
